Category Archives: Opportunities

Leaders from ASU and Mayo to share insights on Cancer Research at Free Virtual Conference in October

Posted on by

Dr. Anna Barker and Dr. George Poste of ASU and Dr. Donald Tindall and Dr. Allan Jaffe of Mayo to share insights at BioConference Live’s Ground-Breaking Cancer Research, Discovery and Therapeutics FREE Virtual Conference in October.

First of Its Kind Online-Only Conference Focusing on Cancer with Live Streaming Video Presentations Delivered by Industry Experts; Earn Continuing Medical Education CreditsContinue reading→

Opportunity Alert – Driving Innovation in Breast Cancer: Startup Challenge

Posted on by

The Avon Foundation (AF), National Institutes of Health National Cancer Institute (NCI) and Center for Advancing Innovation (CAI) have partnered to launch a “first of a kind” Business Plan and Start-Up Challenge for Breast Cancer (BC) inventions that have high commercial viability and are important to public health. This challenge will accelerate the commercialization of Federal agency and AF grantee BC inventions, spur economic growth, and provide Universities a platform to further develop their entrepreneurship learning portfolio.Continue reading→

Opportunity Alert: Submit Your Ideas for Session Presentations at BIO 2014

Posted on by

bio 2014 sessions

The Call for Sessions opens September 5th for the

BIO International Convention

in San Diego, June 23-26, 2014.

Education enhancements in 2014 include: streamlined session tracks organized by role in the industry and featuring international representation among panels; specialty forums with cohesive content and targeted networking receptions.

 

Start planning today: session proposals will be accepted Thursday, September 5 through Thursday, October 3, 2013.

How to develop our suggestion:

  • Review the list of tracks and topic area suggestions to determine which topics are relevant and pressing
  • Talk with colleagues and industry contacts about your idea; brainstorm potential speakers
  • Use the Session Proposal Guide for step-by-step tips to maneuver the online submission process

Please note, proposals for the International Market Briefings (IMB) Track will be accepted separately October 14 – November 4, 2013.

With the 2014 BIO International Convention being held in San Diego, this is a great opportunity to show the world what Arizona has to offer.

QUESTIONS?  If you have any questions about your topic, how to submit, etc. Email BIO at program@bio.org.

Visit convention.bio.org/pitch for more information.

 

 

Opportunity Alert: Four NIH SBIR Programs Now Open for Applications

Posted on by

NCI PREVENT Cancer Program

The NCI PREVENT Cancer Program provides resources to move novel cancer-preventive chemical or biological agents and biomarkers towards clinical testing. Through a partnership with NCI, promising chemopreventive agents will be optimized and tested with the goals of filing an Investigational New Drug application with the U.S. FDA and entering the agent into clinical testing. Click here to learn more. The next deadline to apply is October 7, 2013.

NCI NExT Program

The NCI Experimental Therapeutics (NExT) Program consolidates NCI’s anticancer drug discovery and development resources in support of a goal-driven therapeutics pipeline. NCI partners with researchers from industry or academia to facilitate the milestone-driven progression of new anticancer drugs and imaging agents towards clinical evaluation and registration. Click here to learn more. The next deadline to apply is October 15, 2013.

NCI CADP

The NCI Clinical Assay Development Program (CADP) provides resources for clinical assay validation to assist with the development of assays that may predict therapy response or prognostic behavior of a diagnosed cancer, primarily for use in clinical trials. Click here to learn more. The next deadline to apply is October 15, 2013.

NCATS Therapeutics for Rare and Neglected Disease (TRND) Program

The National Center for Advancing Translational Sciences (NCATS) is pleased to announce an open opportunity to submit proposals to collaborate with the Therapeutics for Rare and Neglected Diseases (TRND) program.

The TRND program supports preclinical and early clinical development of new drugs for rare and neglected tropical diseases by establishing collaborative partnerships with external researchers. Intended candidates for collaboration will be researchers who have promising leads and disease/target knowledge, but who lack the expertise or resources to fully develop these projects into clinical stage programs attractive to biopharmaceutical or other suitable organizations. TRND seeks to partner with academic laboratories, not-for-profit organizations, and for-profit companies. Foreign organizations are eligible to apply. TRND provides significant in-kind research support, but no direct external funding is available.Interested applicants may visit TRND on the web to learn more about the program, and can refer to the current NIH Guide Notice for more information.

Interested applicants must contact the TRND Solicitation Coordinator by email (TRND@mail.nih.gov) to initiate a pre-screening / Letter of Intent (LOI) process. Applications are made through the online proposal system, proposalCENTRAL (https://proposalcentral.altum.com/).

LOIs must be completed no later than September 16, 2013. Final applications are due by September 30, 2013.